ESGE and Public Advocacy.

Endoscopy

Gastroenterology and Endoscopy Unit, Edouard Herriot Hospital, LYON, France.

Published: June 2024

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-2277-2204DOI Listing

Publication Analysis

Top Keywords

esge public
4
public advocacy
4
esge
1
advocacy
1

Similar Publications

Background: The diagnosis of rare uterine leiomyosarcoma (uLMS) remains a challenge given the high incidence rates of benign uterine tumors such as leiomyoma (LM). In the last decade, several clinical scores and blood serum markers have been proposed. The aim of this study is to validate and update the pLMS clinical scoring system, evaluating the accuracy of the scoring system by Zhang et al.

View Article and Find Full Text PDF

Background And Study Aims: Piecemeal EMR of large (≥20mm) non-pedunculated colorectal polyps (LNPCPs) is succeeded by a 6-month surveillance endoscopy to evaluate the post-EMR scar for recurrence. Data from expert centers suggest that routine tattoo placement and scar biopsies can be omitted, but data from community hospitals are lacking.

Patients And Methods: In a post-hoc analysis of the STAR-LNPCP study (NTR7477), containing prospective data on 6-month post-pEMR scar assessments in 30 Dutch community hospitals (October 2019 to May 2022), the agreement between optical assessment and histological confirmation by routine biopsies was evaluated.

View Article and Find Full Text PDF

1:  The European Society of Gastrointestinal Endoscopy (ESGE) adheres to the overarching principles of equality of opportunity, fair treatment, nondiscrimination, and diversity of health care professionals. 2:  ESGE strongly supports the creation of collaborations within and between national and international endoscopy societies to disseminate the principles of diversity, equality, and inclusion (DEI) in the field of gastrointestinal (GI) endoscopy. 3:  ESGE aims to reflect the diversity of its membership in all its scientific and educational activities.

View Article and Find Full Text PDF

Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE.

Lancet Oncol

November 2024

Université Paris Saclay, Paris, France; Department of Reproductive Medicine and Fertility Preservation, Hopital Antoine Béclère, Clamart, France; Department of Reproductive Medicine and Fertility Preservation, Hopital Jean Verdier, Bondy, France.

Article Synopsis
  • - The European Society of Gynaecological Oncology, alongside other societies, created evidence-based guidelines for fertility-sparing strategies in patients with cervical and ovarian cancers, as well as borderline ovarian tumors.
  • - These guidelines were developed through a thorough literature review and involved a diverse group of 25 experts in multiple medical fields, ensuring a comprehensive approach.
  • - Prior to release, the guidelines were vetted by 121 independent cancer care professionals and patient representatives, addressing key aspects of initial management, fertility optimization, and future pregnancy desires.
View Article and Find Full Text PDF

The incidental finding of endometrial thickness (ET) >4 mm in the absence of postmenopausal bleeding (PMB) is a common cause of referring women to secondary care. However, there is lack of consensus amongst gynecologists as regards the management. It is estimated that up to 15 % of endometrial cancers occur in women without PMB.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!